Your browser doesn't support javascript.
loading
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.
Liontos, Michalis; Sotiropoulou, Maria; Kaparelou, Maria; Tzannis, Kimon; Tsironis, George; Kyriazoglou, Anastasios; Tsiara, Anna; Zakopoulou, Roubini; Koutsoukos, Konstantinos; Zagouri, Flora; Thomakos, Nikolaos; Haidopoulos, Dimitrios; Rodolakis, Alexandros; Dimopoulos, Meletios A; Bamias, Aristotelis.
Afiliación
  • Liontos M; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Electronic address: mliontos@gmail.com.
  • Sotiropoulou M; Department of Pathology, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Kaparelou M; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Tzannis K; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Tsironis G; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Kyriazoglou A; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Tsiara A; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Zakopoulou R; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Koutsoukos K; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Zagouri F; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Thomakos N; Department of Obstetrics and Gynaecology; Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Haidopoulos D; Department of Obstetrics and Gynaecology; Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Rodolakis A; Department of Obstetrics and Gynaecology; Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Bamias A; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Gynecol Oncol ; 157(3): 599-605, 2020 06.
Article en En | MEDLINE | ID: mdl-32173048
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos / Carcinoma Epitelial de Ovario Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos / Carcinoma Epitelial de Ovario Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article